Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 2

1(20.0%)

5Total

N/A(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05286619Phase 2Recruiting

A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)

Role: collaborator

NCT06250166Not ApplicableRecruiting

Feasibility, Acceptability, and Effectiveness of an Individualized Plant-based (iPLANT) Diet Plan in Colorectal Cancer: Mixed Method Embedded Design

Role: lead

NCT05867810Completed

Nutritional Status Among Upper Gastrointestinal Cancer Patients Upon Admission

Role: collaborator

NCT04678349Not ApplicableCompleted

The Role of Partial Hydrolyzed Guar Gum in High Stoma Output Management Among Cancer Patients With Ileostomy

Role: collaborator

NCT04643626Not ApplicableCompleted

The Impact of Artificial Intelligence Dietary Smartphone Application on Nutritional Status Among Cancer Patients

Role: collaborator

NCT04889378Completed

Change of Body Composition and Functional Status Following Short-term Pre-habilitation Among Morbidly Obese Patients Before Bariatric Surgery

Role: collaborator

NCT03688646Not ApplicableUnknown

Efficacy of ONS Supplementation in HNC Outpatient Under Treatment

Role: lead

All 7 trials loaded